trial · primary record
Magnesiocard
Metastatic NSCLC - Non-Small Cell Lung Cancer
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 230 |
| Primary completion | 2035-03-31 |
| Primary endpoint | Primary endpoint of Phase II part: Progression-free survival (PFS) |
| Registry ID | NCT07149649 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:45.981Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07149649
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.